IP Library Granted Patent US 8,343,531
Granted Patent B2
US 8,343,531 · App. 12/226,480 · Granted Jan 1, 2013

Composition containing peptide as active ingredient

Assignee: Meiji Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,531
App. No.
12/226,480
Granted
Jan 1, 2013
Kind
B2
Abstract

The invention provides a composition used for promoting glucose uptake, which comprises a peptide having an effect of promoting glucose uptake as the active ingredient, as well as a composition comprising a dipeptide containing leucine and/or isoleucine as the active ingredient. The composition is effective in preventing or treating diabetes mellitus or an elevation of blood glucose level, in promoting glycogen storage, or in enhancing physical strength, enhancing athletic ability, improving endurance performance or relieving fatigue.

Claims (20)

1. A composition for promoting glucose uptake, comprising dipeptides having an effect of promoting glucose uptake as the active ingredient, wherein the dipeptides consist of Ile-Leu, Leu-Ala, and at least one member selected from the group consisting of Ile-Trp, Ala-Leu, Val-Leu, Gly-Leu, Asp-Leu, Lys-Ile, Leu-Leu, Ile-Ile, Leu-Ile, Ile-Asn, Leu-Glu, Leu-Val, and Ile-Val.

2. A composition for promoting glucose uptake, comprising dipeptides having an effect of promoting glucose uptake as the active ingredient, wherein the dipeptides comprise Ile-Leu, Ile-Trp, Val-Leu, Leu-Ile, and at least one member selected from the group consisting of Ala-Leu, Gly-Leu, Asp-Leu, Lys-Ile, Leu-Leu, Ile-Ile, Ile-Asn, Leu-Ala, Leu-Glu, Leu-Val, and Ile-Val.

3. A composition for promoting glucose uptake, comprising dipeptides having an effect of promoting glucose uptake as the active ingredient, wherein the dipeptides consist of Ile-Leu, Leu-Leu, Ile-Ile, and at least one member selected from the group consisting of Ile-Trp, Ala-Leu, Val-Leu, Gly-Leu, Asp-Leu, Lys-Ile, Leu-Ile, Ile-Asn, Leu-Ala, Leu-Glu, Leu-Val, and Ile-Val.

4. A composition for promoting glucose uptake, comprising dipeptides having an effect of promoting glucose uptake as the active ingredient, wherein the dipeptides comprise Ile-Leu, Ile-Trp, Ala-Leu, Val-Leu, Gly-Leu, Asp-Leu, Lys-Ile, Leu-Leu, Ile-Ile, Leu-Ile, Ile-Asn, Leu-Ala, Leu-Glu, Leu-Val, and Ile-Val.

5. The composition according to claim 4 , wherein the composition is a dipeptide-containing protein hydrolysate obtained by hydrolyzing a protein.

6. The composition according to claim 5 , wherein an enzyme used in protein hydrolysis is a protease derived from Aspergillus and/or a protease derived from Bacillus.

7. The composition according to claim 6 , wherein the enzyme used in protein hydrolysis is a combination of trypsin and/or pepsin in addition to a protease derived from Aspergillus and/or a protease derived from Bacillus.

8. The composition according to claim 5 , wherein the protein is at least one member selected from the group consisting of casein, soybean protein, wheat gluten, milk whey protein, and beef.

9. The composition according to claim 4 , wherein the dipeptide has an action of promoting glucose uptake into muscle cells.

10. A food which comprises the composition according to claim 1 .

11. A food which comprises the composition according to claim 2 .

12. A food which comprises the composition according to claim 3 .

13. A food which comprises the composition according to claim 4 .

14. A pharmaceutical composition which comprises the composition according to claim 4 .

15. A method for preventing or treating diabetes mellitus or an elevation of blood glucose level by administering the composition according to claim 4 .

16. A method for promoting glycogen storage in tissues by administering the composition according to claim 4 .

17. A method for enhancing physical strength, enhancing athletic ability, improving endurance performance, or relieving fatigue by administering the composition according to claim 4 .

18. A process for producing the composition according to claim 4 , which comprises hydrolyzing a protein using an enzyme.

19. A process for producing the composition according to claim 16 , wherein an enzyme used in protein hydrolysis is a protease derived from Aspergillus and/or a protease derived from Bacillus.

20. A process for producing the composition according to claim 17 , wherein the enzyme used in protein hydrolysis is a combination of trypsin and/or pepsin in addition to a protease derived from Aspergillus and/or a protease derived from Bacillus.

Assignments (3)
CHANGE OF NAME Recorded Dec 8, 2011
From: MEIJI SEIKA KAISHA, LTD.
To: MEIJI SEIKA PHARMA CO., LTD.
Reel/Frame 027351/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2011
From: MEIJI SEIKA PHARMA CO., LTD.
To: MEIJI CO., LTD.
Reel/Frame 027353/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2009
From: MORIFUJI, MASASHI; KURASHIGE, KEIKO; SANBONGI, CHIAKI
To: MEIJI SEIKA KAISHA, LTD.
Reel/Frame 022088/0369 →
Priority Claims (1)
JP 2006-117439 · Apr 21, 2006 · national
Continuity (1)
Related Publication 20090124560A1 · May 14, 2009